ACS Applied Materials & Interfaces,
Год журнала:
2024,
Номер
17(1), С. 725 - 738
Опубликована: Дек. 16, 2024
Targeting
tumor
markers
is
one
of
the
most
important
approaches
to
therapy,
and
"suicide"
pattern
marker
response
a
very
challenging
study.
Telomerase,
as
key
factors
associated
with
human
longevity
cancer
progression,
considered
be
an
emerging
biomarker
for
diagnosis.
The
targeted
drug
delivery
nanobomb─BIBR1532@HSN/FQDNA/MUC1
aptamer
(B@HDA)
prepared
in
this
study
based
on
hollow
silica
nanoparticles
(HSN)
CRISPR
systems.
Amino-modified
FQDNA
amino-modified
MUC1
are
covalently
attached
surface
carboxyl-functionalized
HSN.
modified
directs
nanobomb
specifically
target
breast
cells
(MCF-7)
sequesters
telomerase
inhibitor
(BIBR1532)
within
Telomerase
primers
(TPs)
recognized
by
highly
expressed
MCF-7
elongated
form
DNA
substrates.
substrate
pairs
crRNA
bases
effectively
activate
CRISPR-Cas12a.
activated
CRISPR-Cas12a
precisely
cut
FQDNA,
releasing
BIBR1532,
which
inhibits
activity.
This
strategy
achieves
"suicide".
described
above
has
following
advantages.
(1)
"closing"
effect
contributes
reducing
nonspecific
release
BIBR1532.
(2)
B@HDA,
combined
CRISPR,
regulates
mitochondrial
dysfunction
cell
senescence
cells.
(3)
In
tumor-bearing
mouse
model,
exhibits
good
biocompatibility
obvious
ablation
tumors,
suggesting
potential
application
prospects
across
wide
range
lines.
summary,
proposed
provides
tunable
switch
approach
specific
inhibition
reduction
growth,
representing
promising
avenue
promoting
treating
cancer.
Nucleic Acids Research,
Год журнала:
2025,
Номер
53(2)
Опубликована: Янв. 11, 2025
Abstract
We
present
a
robust
‘splice-at-will’
CRISPR
RNA
(crRNA)
engineering
mechanism
that
overcomes
the
limitations
of
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)/Cas
system
in
directly
detecting
ultrashort
RNAs.
In
this
strategy,
an
intact
Cas12a
crRNA
can
be
split
from
almost
any
site
spacer
region
to
obtain
truncated
(tcrRNA)
cannot
activate
even
after
binding
auxiliary
DNA
activator.
While
splicing
tcrRNAs
with
moiety
RNA,
formed
combination
work
together
efficiently,
enabling
engineering.
Importantly,
exhibits
same
trans-cleavage
activation
efficiency
as
conventional
crRNA.
Therefore,
by
rationally
designing
activator
conserved
tcrRNA-complementary
sequence
and
arbitrary
RNA-of-interest
recognition
domain,
general
sensing
is
established
utilizes
traditional
DNA-activated
detect
This
strategy
could
faithfully
sequences
6–8
nt,
which
achieved
Cas13a
systems.
Additionally,
through
flexible
design,
our
method
precisely
distinguish
single-base
differences
microRNA
other
sequences.
has
significantly
expanded
Cas12a-based
diagnostic
toolbox
opened
new
avenues
for
detection.
CRISPR/Cas
12a
system
based
nucleic
acid
and
non-nucleic
targets
detection
faces
two
challenges
including
(1)
multiple
crRNAs
are
needed
for
biomarkers
(2)
insufficient
sensitivity
resulted
from
photobleaching
of
fluorescent
dyes
the
low
kinetic
cleavage
rate
a
traditional
single-strand
(ssDNA)
reporter.
To
address
these
limitations,
we
developed
programmable
DNA
nanoswitch
(NS)-regulated
plasmonic
CRISPR/Cas12a-gold
nanostars
(Au
NSTs)
reporter
platform
with
assistance
spatial
confinement
effect.
Through
simply
programming
target
recognition
sequence
in
NS,
only
one
crRNA
is
required
to
detect
both
biomarkers.
The
limit
decreased
by
∼196-fold
miRNA-375
122-fold
prostate-specific
antigen
(PSA),
respectively.
Moreover,
versatile
evaluation
PSA
clinical
urine
samples
can
also
be
achieved,
according
which
prostate
cancer
healthy
groups
well
identified.
Nucleic Acids Research,
Год журнала:
2025,
Номер
53(3)
Опубликована: Янв. 24, 2025
Abstract
CRISPR-Cas12a
technology
has
transformative
potential,
but
as
its
applications
grow,
enhancing
inherent
functionalities
is
essential
to
meet
diverse
demands.
Here,
we
reveal
a
regulatory
mechanism
for
LbCas12a
through
direct
repeat
(DR)
region
3′
end
modifications
and
de-modifications,
which
can
regulate
LbCas12a’s
cis-
trans-cleavage
activities.
We
extensively
explored
the
effects
of
introducing
phosphorylation,
DNA,
photo-cleavable
linker,
DNA
at
DR
on
functionality.
find
that
temporary
inhibitory
function
Cas12a
be
reactivated
by
modification
corresponding
substances,
such
alkaline
phosphatase
(ALP),
immunoglobulin
G
(IgG),
alpha-fetoprotein
(AFP),
exonucleases,
ultraviolet
radiation,
glycosylases,
greatly
expand
scope
application
Cas12a.
Clinical
demonstrated
promising
results
in
ALP,
AFP,
trace
Epstein–Barr
virus
detection
compared
gold
standard
methods.
Our
research
provides
valuable
insights
into
regulating
activity
significantly
expands
potential
clinical
targets,
paving
way
future
universal
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)
diagnostic
strategies.
Analytical Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 12, 2025
The
CRISPR/Cas12a
system
has
emerged
as
a
powerful
tool
in
biosensing
due
to
its
unique
trans-cleavage
activity.
This
study
conducted
an
in-depth
investigation
of
the
modulatory
capabilities
this
system,
particularly
focusing
on
5'-end
modifications
activator
strand,
and
found
that
introducing
hairpin
structure
(HP)
at
which
was
designed
based
RESET
effect,
can
effectively
suppress
strand's
ability
activate
activity
system.
suppression
is
independent
HP's
relation
strand
type
linker
used
(DNA,
RNA
or
peptide).
Detaching
HP
from
restores
system's
These
findings
enrich
development
CRISPR/Cas12a-based
biosensors,
expand
their
application
beyond
DNA-based
target
detection
peptide
sequence-based
recognition.
Based
discovery,
we
constructed
sensitive
biosensor
for
caspase-3
(Casp-3),
key
executor
apoptosis,
by
linking
with
containing
Casp-3
recognition
site.
proposed
been
validated
sensitivity
specificity
detecting
Casp-3,
well
monitoring
drug-induced
apoptosis
through
imaging
living
cells,
providing
valuable
studying
apoptotic
process,
screening
drugs,
assessing
drug
efficacy,
evaluating
treatment
outcomes.
strategy
also
shows
promise
other
peptide-based
targets,
broadening
horizons
early
disease
biomarker
timely
therapeutic
interventions.
Analytical Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 20, 2025
The
CRISPR-Cas
system,
particularly
CRISPR-Cas12a
and
CRISPR-Cas13a,
has
been
widely
utilized
in
constructing
various
biosensors
due
to
their
"trans-cleavage"
ability
as
a
means
of
signal
amplification.
However,
this
universal
characteristic
also
presents
challenge
for
realizing
multiplexed
bioanalysis.
Besides,
potential
cascading
interference
complicated
design
are
notable
obstacles
Herein,
we
propose
mass
spectrometry
method
that
leverages
the
CRISPR-Cas12a/13a
system
achieve
simultaneous
detection
ctDNA
miRNA.
Based
on
properties
two
types
nanoparticle
reporter
probes
have
engineered,
using
cancer-related
biomarkers
miR-21
our
model
analytes.
tags,
which
intrinsically
incorporated
millions
detectable
atoms,
combined
with
CRISPR-Cas12a/Cas13a
system's
ability,
allow
proposed
strategy
fmol-level
limits
without
any
nucleic
acid
amplification
procedures.
assay
was
successfully
applied
human
serum
samples,
demonstrating
its
early
disease
diagnosis
progression
tracking.
Analytical Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 21, 2025
MicroRNAs
(miRNAs)
are
small
noncoding
RNAs
that
regulate
gene
expression
and
implicated
in
various
diseases,
including
cancer.
Due
to
their
critical
role
diagnostics,
there
is
a
growing
need
for
sensitive,
specific,
rapid
detection
methods
miRNAs.
In
this
study,
we
present
dual-accelerated
signal
amplification
platform
miRNA
biosensing,
which
integrates
spatial
confining
catalytic
hairpin
assembly
(SC-CHA)
with
spherical
CRISPR/Cas12a
(S-CRISPR/Cas12a)
system
(SC-CHA@S-CRISPR/Cas12a)
trans-cleavage
of
DNA
reporters.
The
method
employs
biotinylated
palindrome-rich
sequence
(PAS)
form
nanoballs,
serve
as
scaffold
the
operation
SC-CHA
upon
binding.
products
bind
crRNA
Cas
12a
protein,
activating
S-CRISPR/Cas12a
cleave
reporter
generate
detectable
fluorescence
signal.
uniqueness
lies
combined
use
nanoballs
reporters,
both
significantly
accelerate
reaction
kinetics,
resulting
generation.
Additionally,
nanostructure,
integrated
system,
greatly
enhances
biostability
accelerating
kinetics.
These
features
enable
exhibit
high
sensitivity,
limit
(LOD)
low
13.75
fM,
excellent
specificity,
successfully
distinguishing
miRNA-21
from
other
assay
also
biostable,
demonstrating
reliable
performance
complex
biological
samples
such
human
serum.
This
dual-acceleration
approach
offers
promising
solution
rapid,
specific
potential
applications
early
cancer
diagnosis
clinical
monitoring.
Chemical Communications,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Nucleic
acid-functionalized
metallic
nanoparticles
(N-MNPs)
precisely
integrate
the
advantageous
characteristics
of
nucleic
acids
and
nanomaterials,
offering
various
abilities
such
as
resistance
to
enzymatic
degradation,
penetration
physiological
barriers,
controllable
mobility,
biomolecular
recognition,
programmable
self-assembly,
dynamic
structure-function
transformation.
These
properties
demonstrate
significant
potential
in
field
biomedical
diagnostics
therapeutics.
In
this
review,
we
examine
recent
advancements
construction
theranostic
applications
N-MNPs.
We
briefly
summarize
methodologies
employed
conjugation
with
formation
their
superstructural
assemblies.
highlight
representative
N-MNPs
diagnosis,
imaging,
smart
delivery
agents.
also
discuss
challenges
currently
faced
provide
an
outlook
on
future
development
directions
application
prospects.
Analytical Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 11, 2025
CRISPR-Cas
systems
represent
a
highly
programmable
and
precise
nucleic
acid-targeting
platform,
which
has
been
strategically
engineered
as
versatile
toolkit
for
biosensing
bioimaging
applications.
Nevertheless,
their
analytical
performance
is
constrained
by
inherent
functional
activity
limitations
of
natural
CRISPR/Cas
systems,
underscoring
the
critical
role
molecular
engineering
in
enhancing
capabilities.
This
review
comprehensively
examines
recent
advancements
ribonucleoproteins
(RNPs)
to
enhance
capabilities
advanced
detection
cellular
imaging.
We
explore
innovative
strategies
developing
enhanced
RNPs,
including
Cas
protein
through
mutagenesis
fusion
techniques,
guide
RNA
via
chemical
structural
modifications.
Furthermore,
we
evaluate
these
RNPs'
applications
sensitive
biomarker
live-cell
genomic
DNA
monitoring,
while
analyzing
current
challenges
prospective
developments
RNP
bioimaging.
ACS Applied Bio Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
In-situ
fabrication
of
nucleic
acid
molecular
machines
in
biological
environments
is
desirable
for
smart
theranostic
applications.
However,
given
the
complex
nature
environments,
integration
multiple
functional
modules
into
a
coordinated
machine
remains
challenging.
Recent
advances
nanotechnology
offer
solutions
to
these
challenges.
Here,
we
outline
design
principles
acid–based
tailored
physiological
conditions,
drawing
on
recent
examples.
We
review
cutting-edge
technologies
that
facilitate
their
functionalization
settings,
particularly
presynthesis
modifications
using
unnatural
bases
and
postsynthesis
via
bioorthogonal
chemistry
noncovalent
interactions.
discuss
advantages
limitations
suggest
future
directions
overcome
existing